Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide

Rodney J. Ellis, Hang Zhou, Edward Y. Kim, Pingfu Fu, Deborah A. Kaminsky, Bruce Sodee, Valdir Colussi, Waseet Z. Vance, John P. Spirnak, Carolyn Kim, Martin I. Resnick

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide'. Together they form a unique fingerprint.

Medicine & Life Sciences